{"organizations": [], "uuid": "bc697f79f7f681d8ceb106c47b4c35e288db4b0e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-miragen-therapeutics-announces-new/brief-miragen-therapeutics-announces-new-data-showing-administration-of-mrg-110-improved-tissue-perfusion-and-wound-healing-idUSFWN1S40TU", "country": "US", "domain_rank": 408, "title": "BRIEF-Miragen Therapeutics Announces New Data Showing Administration Of MRG-110 Improved Tissue Perfusion And Wound Healing", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-27T14:19:00.000+03:00", "replies_count": 0, "uuid": "bc697f79f7f681d8ceb106c47b4c35e288db4b0e"}, "author": "", "url": "https://www.reuters.com/article/brief-miragen-therapeutics-announces-new/brief-miragen-therapeutics-announces-new-data-showing-administration-of-mrg-110-improved-tissue-perfusion-and-wound-healing-idUSFWN1S40TU", "ord_in_thread": 0, "title": "BRIEF-Miragen Therapeutics Announces New Data Showing Administration Of MRG-110 Improved Tissue Perfusion And Wound Healing", "locations": [], "entities": {"persons": [{"name": "miragen", "sentiment": "none"}], "locations": [], "organizations": [{"name": "brief-miragen therapeutics announces new data showing administration", "sentiment": "negative"}, {"name": "therapeutics inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 22 AM / Updated 7 minutes ago BRIEF-Miragen Therapeutics Announces New Data Showing Administration Of MRG-110 Improved Tissue Perfusion And Wound Healing Reuters Staff 1 Min Read\nApril 27 (Reuters) - miRagen Therapeutics Inc:\n* MIRAGEN THERAPEUTICS ANNOUNCES NEW DATA SHOWING ADMINISTRATION OF MRG-110 IMPROVED TISSUE PERFUSION AND WOUND HEALING IN LATE STAGE PRECLINICAL STUDIES\n* MIRAGEN THERAPEUTICS INC - MRG-110 APPEARED TO INCREASE VASCULARIZATION AND REPARATIVE TISSUE FORMATION IN TREATED WOUNDS\n* MIRAGEN THERAPEUTICS INC - MIRAGEN BELIEVES RESULTS SUPPORT EVALUATION IN HUMAN CLINICAL TRIALS\n* MIRAGEN - MRG-110 TREATMENT APPEARED TO LEAD TO MORE WOUNDS UNDERGOING COMPLETE CLOSURE AT EARLIER TIMEPOINTS VERSUS CONTROLS IN HEALTHY NORMAL ANIMALS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)", "external_links": [], "published": "2018-04-27T14:19:00.000+03:00", "crawled": "2018-04-27T15:01:47.002+03:00", "highlightTitle": ""}